Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk

Carnosine is a naturally occurring dipeptide (β-alanine-L-histidine) which supports physiological homeostasis by buffering intracellular pH, chelating metals, and conjugating with and neutralizing toxic aldehydes such as acrolein. However, it is not clear if carnosine can support cardiovascular func...

Full description

Bibliographic Details
Main Authors: Timothy E. O’Toole, Xiaohong Li, Daniel W. Riggs, David J. Hoetker, Shahid P. Baba, Aruni Bhatnagar
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/3/1383
_version_ 1797405862305726464
author Timothy E. O’Toole
Xiaohong Li
Daniel W. Riggs
David J. Hoetker
Shahid P. Baba
Aruni Bhatnagar
author_facet Timothy E. O’Toole
Xiaohong Li
Daniel W. Riggs
David J. Hoetker
Shahid P. Baba
Aruni Bhatnagar
author_sort Timothy E. O’Toole
collection DOAJ
description Carnosine is a naturally occurring dipeptide (β-alanine-L-histidine) which supports physiological homeostasis by buffering intracellular pH, chelating metals, and conjugating with and neutralizing toxic aldehydes such as acrolein. However, it is not clear if carnosine can support cardiovascular function or modify cardiovascular disease (CVD) risk. To examine this, we measured urinary levels of nonconjugated carnosine and its acrolein conjugates (carnosine-propanal and carnosine-propanol) in participants of the Louisville Healthy Heart Study and examined associations with indices of CVD risk. We found that nonconjugated carnosine was significantly associated with hypertension (<i>p</i> = 0.011), heart failure (<i>p</i> = 0.015), those categorized with high CVD risk (<i>p</i> < 0.001), body mass index (BMI; <i>p</i> = 0.007), high sensitivity C-reactive protein (hsCRP; <i>p</i> = 0.026), high-density lipoprotein (HDL; <i>p</i> = 0.007) and certain medication uses. Levels of carnosine-propanal and carnosine-propanol demonstrated significant associations with BMI, blood glucose, HDL and diagnosis of diabetes. Carnosine-propanal was also associated with heart failure (<i>p</i> = 0.045) and hyperlipidemia (<i>p</i> = 0.002), but no associations with myocardial infarction or stroke were identified. We found that the positive associations of carnosine conjugates with diabetes and HDL remain statistically significant (<i>p</i> < 0.05) in an adjusted, linear regression model. These findings suggest that urinary levels of nonconjugated carnosine, carnosine-propanal and carnosine-propanol may be informative biomarkers for the assessment of CVD risk—and particularly reflective of skeletal muscle injury and carnosine depletion in diabetes.
first_indexed 2024-03-09T03:16:24Z
format Article
id doaj.art-d777fb9c3ec94e88bcdb8c809f76a413
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T03:16:24Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d777fb9c3ec94e88bcdb8c809f76a4132023-12-03T15:19:54ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-01-01223138310.3390/ijms22031383Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease RiskTimothy E. O’Toole0Xiaohong Li1Daniel W. Riggs2David J. Hoetker3Shahid P. Baba4Aruni Bhatnagar5Department of Medicine, University of Louisville, Louisville, KY 40202, USADepartment of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, KY 40202, USAChristina Lee Brown Envirome Institute, University of Louisville, Louisville, KY 40208, USADepartment of Medicine, University of Louisville, Louisville, KY 40202, USADepartment of Medicine, University of Louisville, Louisville, KY 40202, USADepartment of Medicine, University of Louisville, Louisville, KY 40202, USACarnosine is a naturally occurring dipeptide (β-alanine-L-histidine) which supports physiological homeostasis by buffering intracellular pH, chelating metals, and conjugating with and neutralizing toxic aldehydes such as acrolein. However, it is not clear if carnosine can support cardiovascular function or modify cardiovascular disease (CVD) risk. To examine this, we measured urinary levels of nonconjugated carnosine and its acrolein conjugates (carnosine-propanal and carnosine-propanol) in participants of the Louisville Healthy Heart Study and examined associations with indices of CVD risk. We found that nonconjugated carnosine was significantly associated with hypertension (<i>p</i> = 0.011), heart failure (<i>p</i> = 0.015), those categorized with high CVD risk (<i>p</i> < 0.001), body mass index (BMI; <i>p</i> = 0.007), high sensitivity C-reactive protein (hsCRP; <i>p</i> = 0.026), high-density lipoprotein (HDL; <i>p</i> = 0.007) and certain medication uses. Levels of carnosine-propanal and carnosine-propanol demonstrated significant associations with BMI, blood glucose, HDL and diagnosis of diabetes. Carnosine-propanal was also associated with heart failure (<i>p</i> = 0.045) and hyperlipidemia (<i>p</i> = 0.002), but no associations with myocardial infarction or stroke were identified. We found that the positive associations of carnosine conjugates with diabetes and HDL remain statistically significant (<i>p</i> < 0.05) in an adjusted, linear regression model. These findings suggest that urinary levels of nonconjugated carnosine, carnosine-propanal and carnosine-propanol may be informative biomarkers for the assessment of CVD risk—and particularly reflective of skeletal muscle injury and carnosine depletion in diabetes.https://www.mdpi.com/1422-0067/22/3/1383carnosineacroleincardiovascular diseasebiomarker
spellingShingle Timothy E. O’Toole
Xiaohong Li
Daniel W. Riggs
David J. Hoetker
Shahid P. Baba
Aruni Bhatnagar
Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
International Journal of Molecular Sciences
carnosine
acrolein
cardiovascular disease
biomarker
title Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
title_full Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
title_fullStr Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
title_full_unstemmed Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
title_short Urinary Levels of the Acrolein Conjugates of Carnosine Are Associated with Cardiovascular Disease Risk
title_sort urinary levels of the acrolein conjugates of carnosine are associated with cardiovascular disease risk
topic carnosine
acrolein
cardiovascular disease
biomarker
url https://www.mdpi.com/1422-0067/22/3/1383
work_keys_str_mv AT timothyeotoole urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk
AT xiaohongli urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk
AT danielwriggs urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk
AT davidjhoetker urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk
AT shahidpbaba urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk
AT arunibhatnagar urinarylevelsoftheacroleinconjugatesofcarnosineareassociatedwithcardiovasculardiseaserisk